Atossa Therapeutics, Inc. (ATOS) stock
ATOSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.81−0.09 (-4.74%)
Close on Nov 18, 2026Market cap $18.06MP/E –Yield –
Atossa Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Atossa Therapeutics's market cap was $20.26M on Nov 11, 2026, against $100.43M a year earlier. Over the last 5 years it ranged from $16.62M to $225.54M, with a median of $107.21M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $20.26M | -73.4% |
| 2025 | Dec 31, 2025 | $76.21M | -35.6% |
| 2024 | Dec 31, 2024 | $118.29M | +7.3% |
| 2023 | Dec 29, 2023 | $110.26M | +64.3% |
| 2022 | Dec 30, 2022 | $67.11M | -66.9% |
| 2021 | Dec 31, 2021 | $202.59M | +1938.0% |
| 2020 | Dec 31, 2020 | $9.94M | -30.7% |
| 2019 | Dec 31, 2019 | $14.33M | +154.5% |
| 2018 | Dec 31, 2018 | $5.63M | +54.5% |
| 2017 | Dec 29, 2017 | $3.65M | -31.7% |
| 2016 | Dec 30, 2016 | $5.34M | -45.2% |
| 2015 | Dec 31, 2015 | $9.74M | -72.3% |
| 2014 | Dec 31, 2014 | $35.13M | -13.2% |
| 2013 | Dec 31, 2013 | $40.47M | -14.4% |
| 2012 | Dec 31, 2012 | $47.27M | – |
See a number that looks wrong?